Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis

Clinical Infectious Diseases

Volumn 27, Issue 3, 1998, Pages 509-512

  Wortmann, Glenn W ^a   Aronson, Naomi E ^b   Byrd, John C ^b   Grever, Michael R ^b   Oster, Charles N ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; HERPES ZOSTER; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SOLDIER;

EID: 0031668723     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514689     Document Type: Article

References (3)

1. Evans T. Leishmaniasis. Infect Dis Clin North Am 1993;7:527-46.
2. Herwaldt B, Berman J. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
3. Gasser R, Magill A, Oster C, Franke E, Grogl M, Berman J. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994;18:83-90.